The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy

被引:116
作者
Tsai, CS
Lai, CH
Wang, CC
Chang, JT
Chang, TC
Tseng, CJ
Hong, JH
机构
[1] Chang Gung Mem Hosp, Dept Radiat Oncol, Tao Yuan, Taiwan
[2] Chang Gung Mem Hosp, Dept Obstet & Gynecol, Tao Yuan, Taiwan
[3] Chang Gung Univ, Sch Med, Dept Med Technol, Tao Yuan, Taiwan
关键词
cervical cancer; postoperative radiotherapy; radical hysterectomy; prognostic factor;
D O I
10.1006/gyno.1999.5527
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose. This study was undertaken to evaluate the efficacy of postoperative radiotherapy (post-OP RT) and to investigate the prognostic factors for early-stage cervical cancer patients who were treated by radical surgery, and the pathological findings suggested a relatively high risk of relapse with surgery alone. Materials and methods. From January 1990 to December 1995, 222 patients with stage IB-IIA cervical cancer, treated by radical surgery and a full course of post-OF RT, were included in this study. The indications for post-OF RT were based on pathological findings, including lymph node metastasis, positive surgical margins, parametrial extension, lymphovascular permeation, and invasion of more than two-thirds of the cervical wall thickness. The radiation dose of external beam was 44-45 Gy to the whole pelvis and 50-54 Gy to the true pelvis. One hundred seventy-two patients also received intravaginal brachytherapy as a local boost. The minimal follow-up period was 2 years. Results. The actuarial 5-year overall and disease-specific survival rates for all patients were 76 and 82%, respectively. The tumor control rate within the pelvis reached 94%, and distant metastasis was the major cause of treatment failure. Univariate analysis of clinical and pathological parameters revealed that clinical stage, bulky tumor size, positive lymph nodes, parametrial extension, and histologic type were significant prognostic factors. After multivariate analysis, only positive lymph nodes (P = 0.01), bulky tumor size (P = 0.02), and parametrial extension (P = 0.05) independently influenced the disease-specific survival (DSS). For patients with lymph node metastasis, the number and location of the nodal involvement significantly affected the prognosis. The 5-year DSS for patients with no, one, and more than one lymph node metastasis were 87, 84, and 61% (P = 0.0001), respectively. Patients with upper pelvic lymph node metastasis had a higher incidence of distant metastasis (50% vs 16% in lower pelvic node group, P = 0.03). Ln the subgroup of single lower pelvic nodal metastasis, the prognosis was similar to that of patients without lymph node involvement (5-year DSS 85% vs 87%, P = 0.71). Conclusion. Our results indicate that post-OP RT can achieve very good local control in stage IB-IIA cervical cancer patients whose pathological findings show risk features for relapse after radical surgery. The prognostic factors for treatment failure identified in this study can be used as selection criteria for clinical trials to test the effects of other adjuvant treatments, such as chemotherapy. Patients with a single lower pelvic lymph node metastasis have a relatively good prognosis and may not need adjuvant treatment beyond radiation therapy, (C) 1999 Academic Press.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 33 条
[1]   POSTOPERATIVE RADIOTHERAPY IN CARCINOMA OF THE CERVIX - TREATMENT RESULTS AND PROGNOSTIC FACTORS [J].
ATKOVAR, G ;
UZEL, O ;
OZSAHIN, M ;
KOCA, S ;
SAHINLER, I ;
OKKAN, S ;
UZEL, R .
RADIOTHERAPY AND ONCOLOGY, 1995, 35 (03) :198-205
[2]   SURVIVAL AND PATTERNS OF RECURRENCE IN CERVICAL-CANCER METASTATIC TO PERIAORTIC LYMPH-NODES - (A GYNECOLOGIC ONCOLOGY GROUP-STUDY) [J].
BERMAN, ML ;
KEYS, H ;
CREASMAN, W ;
DISAIA, P ;
BUNDY, B ;
BLESSING, J .
GYNECOLOGIC ONCOLOGY, 1984, 19 (01) :8-16
[3]   Lymph node metastases and prognosis in patients with stage IA(2) cervical cancer [J].
Buckley, SL ;
Tritz, DM ;
VanLe, L ;
Higgins, R ;
Sevin, BU ;
Ueland, FR ;
DePriest, PD ;
Gallion, HH ;
Bailey, CL ;
Kryscio, RJ ;
Fowler, W ;
Averette, H ;
Vannagell, JR .
GYNECOLOGIC ONCOLOGY, 1996, 63 (01) :4-9
[4]   TOXICITY CRITERIA OF THE RADIATION-THERAPY ONCOLOGY GROUP (RTOG) AND THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER (EORTC) [J].
COX, JD ;
STETZ, J ;
PAJAK, TF .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 31 (05) :1341-1346
[5]   Adjuvant chemotherapy versus chemotherapy plus pelvic irradiation for high-risk cervical cancer patients after radical hysterectomy and pelvic lymphadenectomy (RH-PLND): A randomized phase III trial [J].
Curtin, JP ;
Hoskins, WJ ;
Venkatraman, ES ;
Almadrones, L ;
Podratz, KC ;
Long, H ;
Teneriello, M ;
Averette, H ;
Sevin, BU .
GYNECOLOGIC ONCOLOGY, 1996, 61 (01) :3-10
[6]   A PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF STAGE 1 SQUAMOUS CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, BN ;
FOWLER, WC ;
STEHMAN, FB ;
SEVIN, B ;
CREASMAN, WT ;
MAJOR, F ;
DISAIA, P ;
ZAINO, R .
GYNECOLOGIC ONCOLOGY, 1989, 35 (03) :314-320
[7]   PROSPECTIVE SURGICAL PATHOLOGICAL-STUDY OF DISEASE-FREE INTERVAL IN PATIENTS WITH STAGE IB SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A GYNECOLOGIC ONCOLOGY GROUP-STUDY [J].
DELGADO, G ;
BUNDY, B ;
ZAINO, R ;
SEVIN, BU ;
CREASMAN, WT ;
MAJOR, F .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :352-357
[8]  
Delgado G, 1978, Obstet Gynecol Surv, V33, P174, DOI 10.1097/00006254-197803000-00016
[9]   Postoperative radiation for cervical cancer with pathologic risk factors [J].
Hart, K ;
Han, I ;
Deppe, G ;
Malviya, V ;
Malone, J ;
Christensen, C ;
Chuba, P ;
Porter, A .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 37 (04) :833-838
[10]   The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy [J].
Hong, JH ;
Tsai, CS ;
Chang, JT ;
Wang, CC ;
Lai, CH ;
Lee, SP ;
Tseng, CJ ;
Chang, TC ;
Tang, SG .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (04) :823-830